• Skip to Primary Content
  • Skip to Footer
  • About
    About Mannkind Our Values Executive Leadership Board of Directors History of Innovation
  • Products & Pipeline
    Products & Pipeline Pipeline Chart Clinical Trials About Clinical Trials MannKind Trials Scientific Advisory Board Publications Medical Affairs
  • Partners
    Partnering with Mannkind Technosphere Innholation innovation BluHale Inhalation H-Patch Intelectual property
  • Careers
    Mannkind Careers Locations Department Open Positions Benefits Internships & Fellowships
  • Newsroom
  • Investors
    Investing in Mannkind Events & Presentations Corporate Deck & Fact Sheet Press Releases SEC Filings Financial Information Annual Reports Quarterly Results ESG Stock Information Historic Price Lookup Investment Calculator Ownership Profile Analyst Coverage
Mannkind
  • About
    Our Values Executive Leadership Board of Directors History of Innovation
  • Products & Pipeline
    Pipeline Chart Clinical Trials About Clinical Trials MannKind Trials Scientific Advisory Board Publications Medical Affairs
  • Partners
    Technosphere Inhalation innovation BluHale Inhalation H-Patch Intellectual property
  • Careers
    Locations Departments Open Positions Benefits Internships & Fellowships
  • Newsroom
  • Investors
    Events & Presentations Corporate Deck Press Releases SEC Filings Financial Information Annual Reports Quarterly Results Corporate Governance ESG Stock Information Historic Price Lookup Investment Calculator Ownership Profile Analyst Coverage
  • By using the search function, you agree that any terms entered may be processed or used by MannKind or our vendors supporting our search bar or website in accordance with the MannKind Privacy Notice and Terms of Use.

  1. News & Events
  2. September 29, 2025

  • previous post
  • next post
="mannkind

Make a humann connection with us. Reach out anytime.

contact

sign up for email updates

sign up

Terms of Use Privacy Policy Consumer Health Data Privacy Policy Patent Notices Corporate Governance

©2026 MannKind Corporation. All rights reserved.

announcement-banner-bg

Now FDA Approved:
Furoscix ReadyFlow™

(furosemide injection)

Designed for at-home administration in
seconds via an autoinjector
Learn More
MannKind
MannKind